Pages that link to "Q45863779"

The following pages link to Induction of immune tolerance with recombinant factor VIII in haemophilia A patients with inhibitors. (Q45863779):

Displaying 18 items.

• Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B (Q24195006) (← links)
• Immune tolerance induction: recombinant vs. human-derived product (Q34117221) (← links)
• Immune tolerance induction in patients with haemophilia A with inhibitors: a systematic review (Q35163638) (← links)
• A role for von Willebrand factor in immune tolerance induction in patients with haemophilia A and inhibitors? (Q35176160) (← links)
• Immune tolerance therapy in patients with acquired hemophilia (Q35994817) (← links)
• The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. (Q36480548) (← links)
• Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors. (Q36533453) (← links)
• The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile (Q37032857) (← links)
• Immune tolerance induction in haemophilia: evidence and the way forward (Q37903944) (← links)
• Immune tolerance induction for patients with severe hemophilia A: a critical literature review (Q37912059) (← links)
• Effect of von Willebrand factor on inhibitor eradication in patients with severe haemophilia A: a systematic review. (Q38212494) (← links)
• Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization (Q45838031) (← links)
• Human recombinant DNA-derived antihemophilic factor in the treatment of previously untreated patients with hemophilia A: final report on a hallmark clinical investigation (Q45874814) (← links)
• The principal results of the International Immune Tolerance Study: a randomized dose comparison (Q45875180) (← links)
• How I treat inhibitors in haemophilia. (Q45879927) (← links)
• Management of patients with long-term inhibitors: is immune tolerance an underestimated life-long solution? (Q45884062) (← links)
• Immune tolerance induction in haemophilia A patients with inhibitors by treatment with recombinant factor VIII: a retrospective non-interventional study (Q45885860) (← links)
• octanate®: over 20 years of clinical experience in overcoming challenges in haemophilia A treatment (Q93271828) (← links)